Travere Therapeutics to Participate at Upcoming Investor Conferences
Travere Therapeutics (NASDAQ: TVTX) has announced its participation in four major investor conferences during March 2025. The company will present at the TD Cowen 45th Annual Health Care Conference on March 3 at 9:10 a.m. ET and the Leerink Partners Global Biopharma Conference on March 11 at 9:20 a.m. ET. Additional appearances include the Barclays 27th Annual Global Healthcare Conference and Jefferies Biotech on the Beach Summit, both scheduled for March 12.
Live webcasts will be available for the TD Cowen and Leerink Partners conference presentations through Travere's investor relations website at ir.travere.com/events-presentations. These webcasts will remain accessible for replay up to 30 days after each event.
Travere Therapeutics (NASDAQ: TVTX) ha annunciato la sua partecipazione a quattro importanti conferenze per investitori nel marzo 2025. L'azienda presenterà al TD Cowen 45° Annual Health Care Conference il 3 marzo alle 9:10 a.m. ET e al Leerink Partners Global Biopharma Conference l'11 marzo alle 9:20 a.m. ET. Ulteriori apparizioni includono il Barclays 27° Annual Global Healthcare Conference e il Jefferies Biotech on the Beach Summit, entrambi programmati per il 12 marzo.
Webcast dal vivo saranno disponibili per le presentazioni delle conferenze TD Cowen e Leerink Partners attraverso il sito web delle relazioni con gli investitori di Travere all'indirizzo ir.travere.com/events-presentations. Questi webcast rimarranno accessibili per la riproduzione fino a 30 giorni dopo ciascun evento.
Travere Therapeutics (NASDAQ: TVTX) ha anunciado su participación en cuatro importantes conferencias para inversores durante marzo de 2025. La compañía presentará en la TD Cowen 45ª Conferencia Anual de Atención Médica el 3 de marzo a las 9:10 a.m. ET y en la Conferencia Global de Biofarma de Leerink Partners el 11 de marzo a las 9:20 a.m. ET. Otras apariciones incluyen la 27ª Conferencia Anual Global de Atención Médica de Barclays y la Cumbre de Biotecnología de Jefferies en la Playa, ambas programadas para el 12 de marzo.
Las transmisiones en vivo estarán disponibles para las presentaciones de las conferencias TD Cowen y Leerink Partners a través del sitio web de relaciones con inversores de Travere en ir.travere.com/events-presentations. Estas transmisiones permanecerán accesibles para su reproducción hasta 30 días después de cada evento.
Travere Therapeutics (NASDAQ: TVTX)는 2025년 3월에 열리는 네 개의 주요 투자자 회의에 참여한다고 발표했습니다. 회사는 3월 3일 오전 9시 10분 ET에 TD Cowen 제45회 연례 헬스케어 컨퍼런스에서 발표하고, 3월 11일 오전 9시 20분 ET에 Leerink Partners 글로벌 바이오파마 회의에 참석할 예정입니다. 추가로 Barclays 제27회 연례 글로벌 헬스케어 컨퍼런스와 Jefferies Biotech on the Beach Summit에도 3월 12일에 참석할 예정입니다.
TD Cowen 및 Leerink Partners 회의 발표를 위한 라이브 웹캐스트는 Travere의 투자자 관계 웹사이트 ir.travere.com/events-presentations를 통해 제공됩니다. 이 웹캐스트는 각 이벤트 후 최대 30일 동안 재생할 수 있습니다.
Travere Therapeutics (NASDAQ: TVTX) a annoncé sa participation à quatre grandes conférences pour investisseurs en mars 2025. La société présentera à la 45e Conférence Annuelle de Soins de Santé TD Cowen le 3 mars à 9h10 ET et à la Conférence Biopharma Mondiale de Leerink Partners le 11 mars à 9h20 ET. D'autres apparitions incluent la 27e Conférence Annuelle Mondiale de Soins de Santé Barclays et le Sommet Biotech sur la Plage de Jefferies, tous deux prévus pour le 12 mars.
Des webcasts en direct seront disponibles pour les présentations des conférences TD Cowen et Leerink Partners via le site web des relations investisseurs de Travere à l'adresse ir.travere.com/events-presentations. Ces webcasts resteront accessibles pour rediffusion jusqu'à 30 jours après chaque événement.
Travere Therapeutics (NASDAQ: TVTX) hat seine Teilnahme an vier wichtigen Investorenkonferenzen im März 2025 angekündigt. Das Unternehmen wird am 3. März um 9:10 Uhr ET auf der TD Cowen 45. jährlichen Gesundheitskonferenz und am 11. März um 9:20 Uhr ET auf der Leerink Partners Global Biopharma Conference präsentieren. Weitere Auftritte umfassen die 27. jährliche globale Gesundheitskonferenz von Barclays und den Jefferies Biotech on the Beach Summit, die beide für den 12. März geplant sind.
Live-Webcasts werden für die Präsentationen der TD Cowen- und Leerink Partners-Konferenzen über die Investor-Relations-Website von Travere unter ir.travere.com/events-presentations verfügbar sein. Diese Webcasts bleiben bis zu 30 Tage nach jeder Veranstaltung für die Wiederholung zugänglich.
- None.
- None.
SAN DIEGO, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that company management will participate in the following upcoming investor conferences in March:
TD Cowen 45th Annual Health Care Conference
Presenting on Monday, March 3, 2025, at 9:10 a.m. ET
Leerink Partners Global Biopharma Conference
Presenting on Tuesday, March 11, 2025, at 9:20 a.m. ET
Barclays 27th Annual Global Healthcare Conference
Wednesday, March 12, 2025
Jefferies Biotech on the Beach Summit
Wednesday, March 12, 2025
Live webcasts of the TD Cowen 45th Annual Health Care Conference and Leerink Partners Global Biopharma Conference presentations will be accessible on the Investor page of Travere’s website at ir.travere.com/events-presentations. Replays will be available for up to 30 days following each event.
About Travere Therapeutics
At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families, and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop, and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com.
Contact:
| Investors: 888-969-7879 IR@travere.com | Media: 888-969-7879 mediarelations@travere.com |
FAQ
When is Travere Therapeutics (TVTX) presenting at the TD Cowen Healthcare Conference in March 2025?
Which investor conferences will TVTX attend in March 2025?
How long will TVTX conference presentation webcasts be available for replay?
Where can investors access Travere Therapeutics' (TVTX) conference presentation webcasts?
Which TVTX conference presentations in March 2025 will have live webcasts available?
